The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/II study of onvansertib (PCM-075) in combination with FOLFIRI and bevacizumab for second-line treatment of metastatic colorectal cancer (mCRC) in patients with a KRAS mutation.
 
Heinz-Josef Lenz
Honoraria - Bayer; Bayer; Bayer; Bayer; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Isofol Medical; Isofol Medical; Isofol Medical; Isofol Medical; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Roche
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Roche
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer; Merck Serono; Merck Serono; Merck Serono; Merck Serono
 
Daniel H. Ahn
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Cardinal Health; Cardinal Health; Cardinal Health; Cardinal Health; Celltrion (I); Celltrion (I); Celltrion (I); Celltrion (I); Eisai; Eisai; Eisai; Eisai; Exelixis; Exelixis; Exelixis; Exelixis; Lexicon; Lexicon; Lexicon; Lexicon
 
Maya Ridinger
Employment - Trovagene; Trovagene; Trovagene; Trovagene
Stock and Other Ownership Interests - Trovagene; Trovagene; Trovagene; Trovagene
Travel, Accommodations, Expenses - Trovagene; Trovagene; Trovagene; Trovagene
 
Mark G. Erlander
Employment - Trovagene; Trovagene; Trovagene; Trovagene
Leadership - Trovagene; Trovagene; Trovagene; Trovagene
Stock and Other Ownership Interests - Trovagene; Trovagene; Trovagene; Trovagene
 
Afsaneh Barzi
Consulting or Advisory Role - Bayer Technology System; Bayer Technology System; Bayer Technology System; Bayer Technology System; bioTheranostics; bioTheranostics; bioTheranostics; bioTheranostics; Merrion; Merrion; Merrion; Merrion
Research Funding - Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst)